![April Dovholuk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
April Dovholuk formerly worked at Replimune Group, Inc., as Senior VP-Clinical Development Operations and Centessa Pharmaceuticals Plc, as Senior Vice President-Operations Development from 2023 to 2024.
Dr. Dovholuk received her undergraduate degree from Cornell University.
Former positions of April Dovholuk
| Companies | Position | End |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Chief Operating Officer | 01/11/2024 |
| REPLIMUNE GROUP, INC. | Chief Tech/Sci/R&D Officer | - |
Training of April Dovholuk
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
- Stock Market
- Insiders
- April Dovholuk
